Flex, Cerebras Expand AI Manufacturing Partnership

What happened

Flex announced expansion of manufacturing lines in Milpitas, California for Cerebras CS-3 AI supercomputers, anticipating a 7x increase in production as demand for AI infrastructure accelerates. The deal deepens an existing partnership and underscores Flex's strategic push into high-growth AI data center markets. However, the DeepValue report rates Flex a 'Potential Sell' due to a stock price ($63.68) approximately 74% above a DCF-based intrinsic value of $36.64, with thin net margins (~3%) and flat revenue trends. While the Cerebras expansion is operationally positive, it does not alter the structural challenges of low-margin EMS economics or the rich valuation (P/E ~28x). The risk/reward remains unfavorable at current levels, as the market has already priced in significant future growth.

Implication

While the Cerebras deal is a tangible validation of Flex's AI infrastructure capabilities and could drive revenue growth, the core thesis remains constrained by thin margins (~3% net), stagnant topline, and a stock price that already reflects optimistic assumptions. The DCF suggests fair value near $36, implying 74% downside from current levels. To justify the current multiple, Flex would need sustained FCF above $1bn/year and margin expansion, which are not yet proven. Investors should monitor margin trends and FCF generation closely; any disappointment could lead to a sharp re-rating. The expansion is a positive catalyst but insufficient to overcome the poor risk/reward at current prices.

Thesis delta

The partnership expansion confirms Flex's traction in AI infrastructure, a key growth driver, but does not change the fundamental valuation concern. The stock's 65% run-up over 12 months already prices in such wins. Thesis shifts from 'Potential Sell' to a more nuanced 'Wait' only if sustained FCF and margin improvements materialize; otherwise, the lack of margin of safety persists.